Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Pneumoconiosis Market Size

ID: MRFR//3218-HCR | 90 Pages | Author: Rahul Gotadki| May 2024

The essential driver of the pneumoconiosis market is word related exposure to harmful dust. Industries such as mining, construction, and assembling contribute significantly to the predominance of this disease. As workers are exposed to dust containing silica, coal, or asbestos, the interest for pneumoconiosis-related medical care services and treatments rises.
The worldwide pattern towards industrialization significantly influences the pneumoconiosis market. As additional countries go through industrial turn of events, the quantity of workers exposed to harmful dust increases. This expansion of industrial activities directly correlates with the growth of the pneumoconiosis market, as additional cases are diagnosed and treated.
The convenience and accessibility of medical services facilities assume a vital part in shaping the pneumoconiosis market. Regions with deep rooted medical services infrastructure are better prepared to diagnose and treat cases instantly. Disparities in medical care access can prompt variations in the pervasiveness and severity of pneumoconiosis, influencing the market similarly.
Progressing research and advancement efforts focused on pneumoconiosis treatment options impact the market landscape. The presentation of novel therapies, medications, or clinical interventions can significantly modify the direction of the market by giving more compelling and proficient solutions for patients.
Segment factors, such as age and orientation distribution in the labor force, add to the pneumoconiosis market. Age groups or genders might be more susceptible to the disease because of the idea of their work or other wellbeing considerations, affecting the general market trends.

Pneumoconiosis Market Scenario:

The pneumoconiosis market is anticipated to reach USD 2,280.88 Million by 2030 at 9.40% CAGR during the forecast period 2022-2030.

Pneumoconiosis is a restrictive and occupational lung disease caused by inhalation of dust. There are a number of different agents that, when inhaled, can potentially cause pneumoconiosis. Organic and inorganic agents are responsible for causing this diseases. According to the Centers for Disease Control and Prevention, in 2013, 260,000 deaths occurred due to pneumoconiosis. Increasing prevalence of pneumoconiosis, increasing smoking population, and rising air pollution have driven the growth of the market. Approximately 75% of non-asbestos pneumoconiosis cases recorded under the IIDB scheme in 2009 were from individuals that are over 65 years. According to the Centers for Disease Control and Prevention, cigarette smoking is the leading cause of death in the United States, accounting for over 480,000 deaths every year. Moreover, increasing geriatric population, increasing healthcare expenditure, and strong encouragement from the government have also contributed to the growth of the market. According to research, smoking increases the possibility of pneumoconiosis; more than 60% of the global population smokes, this has increased the risk of pneumoconiosis and contributed in the growth of the market. However, side effects associated with the treatment and lack of long term treatment may lead to hinder the growth of the market.

Intended Audience

  • Biotechnological institutes

  • Pharmaceutical companies

  • Government and Private Laboratories

  • Research and Development (R&D) Companies

  • Market Research and Consulting Service Providers

  • Medical Research Laboratories

Figure 1:- Global Pneumoconiosis market share, by causes Pneumoconiosis Market

Sources: WHO, annual reports, press release, white paper, and company presentation 


The pneumoconiosis market is segmented on the basis of types, causes, therapy, and end users.

On the basis of types, the pneumoconiosis market is segmented into asbestosis, berylliosis, byssinosis, coal workers pneumoconiosis, silicosis, and others.

On the basis of causes, the pneumoconiosis market is categorised into organic dusts, non-organic substances, and others. Organic substances are further segmented into hay, malt, mushrooms, and others. Non organic substances are further segmented into sulphur dioxide, ammonia, nitrogen dioxide, and others.

On the basis of therapy, the pneumoconiosis market is segmented into diagnosis, and treatment. Diagnosis is further segmented into chest X-ray, CT scan, and others. Treatment is further classified into mucolytic agent, antibiotic, and others.

On the basis of end users, the pneumoconiosis market is segmented into hospital, clinics, and others. 

Regional Analysis

America dominates the pneumoconiosis market owing to large patient population. Apart from this, increasing number of patients, changing lifestyle and increasing healthcare expenditure have boosted the growth of the market in America. According to the Centers for Disease Control and Prevention, in 2015, about 15 in every 100 U.S. adults aged over 18 years smoked cigarettes. Which is equals around 36.5 million adults in the United States currently smoke cigarettes. Increasing smoking population increases the possibility of causing the disease. Additionally, increasing awareness among the people regarding different diagnostic procedures and well-developed technology has also contributed to the growth of the market.

Europe is the second largest pneumoconiosis market, which is followed by Asia Pacific. Huge smoking population, availability of funds for research, and government support for research & development will drive the market.

Asia Pacific is the fastest growing region for the market due to the presence of a huge patient population, continuously developing economies, and presence of huge opportunity in the market.

On the other hand, the Middle East & Africa has the least share in the pneumoconiosis market due to presence of poor economy especially in Africa region. Majority of the market of this region is held by Middle East due to well-developed healthcare sector and huge healthcare expenditure. 

Research MethodologyPneumoconiosis Market-

Sources: WHO, annual reports, press release, white paper, and company presentation 

Key players for pneumoconiosis market

The key players for the pneumoconiosis market Abbott (US) Eli Lilly (U.S.), Sunpharma (India), Sanofi (France), Novo Nordisk (Denmark), Novartis (Switzerland), Abbott (U.S.), AstraZeneca (U.K), Merck & Co. (U.S.), Pfizer (U.S.), Svizera Healthcare (India), F. Hoffman La Roche AG (Germany), and Bayer Cropscience Ltd. (U.S.).


Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.